Alpha Teknova (TKNO) Cash from Investing Activities (2020 - 2026)

Alpha Teknova's (TKNO) quarterly Cash from Investing Activities came in at $1.8 million in Q1 2026, down 51.86% year-on-year from $3.8 million in Q1 2025, and down 42.59% on a QoQ basis from $3.2 million in Q4 2025.

Alpha Teknova (TKNO) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Alpha Teknova (TKNO) has 7 years of Cash from Investing Activities data on file, last reported at $1.8 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 51.86% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $8.7 million, a 137.15% increase from a year earlier, with the FY2025 full-year figure at $10.7 million, up 139.23% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $1.8 million, down from $3.2 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for TKNO reached as high as $3.8 million in Q1 2025 and fell as low as -$25.8 million in Q3 2024.
  • Historically, Cash from Investing Activities has averaged -$3.0 million across 5 years, with a median of -$972000.0 in 2023.
  • Across the five-year window, Cash from Investing Activities plunged 2550.1% in 2024 and jumped 29315.38% in 2025, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$4.7 million in 2022, then surged by 97.57% to -$115000.0 in 2023, then slumped by 1129.57% to -$1.4 million in 2024, then soared by 326.8% to $3.2 million in 2025, then slumped by 42.59% to $1.8 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $1.8 million in Q1 2026, $3.2 million in Q4 2025, and $1.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 229.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 743.70 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -60.00 Mn
10 Alpha Teknova 278.75 Mn 260.97 Mn 3.78 Mn 1.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.84 Mn
Mar 31, 2026 1.84 Mn
Dec 31, 2025 3.21 Mn
Dec 31, 2025 3.21 Mn
Sep 30, 2025 1.64 Mn
Sep 30, 2025 1.64 Mn
Jun 30, 2025 2.03 Mn
Jun 30, 2025 2.03 Mn
Mar 31, 2025 3.82 Mn
Mar 31, 2025 3.82 Mn
Dec 31, 2024 -1.41 Mn
Dec 31, 2024 -1.41 Mn
Sep 30, 2024 -25.76 Mn
Sep 30, 2024 -25.76 Mn
Jun 30, 2024 -115,000.00
Jun 30, 2024 -115,000.00
Mar 31, 2024 13,000.00
Mar 31, 2024 13,000.00
Dec 31, 2023 -115,000.00
Dec 31, 2023 -115,000.00